Home News Second Shot In Clinical Trial Of Novavax COVID Vaccine Comes With A Dose Of Confidence back to News
minute read
Data from studies done in the United Kingdom show the COVID-19 vaccine made by Novavax is roughly 90% effective. That’s great news as the Phase 3 clinical trial of that vaccine in the United States is underway.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
